Aravive
Houston, US · Texas corporation · 2 known investors
Biotech
Founders & leadership
RH
Rudy HowardChief Financial Officer
FN
Fredric N. EshelmanExecutive Chairman of the Board of Directors
SC
Sigurd C. KirkDirector
MW
Michael W. RogersDirector
PT
Peter T.C. HoDirector
RB
Robert B. GellerChief Medical Officer
GM
Gail McIntyreChief Executive Officer
LS
Leonard Scott DoveChief Operating Officer
EZ
Eric ZhangDirector
AG
Amato GiacciaDirector
JA
John A. HohneckerDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$41.6MraisedOct 2022 · 17 investors · BiotechnologyRule 506(b)
▶$41.6MraisedOct 2022 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rudy HowardExecutive Officer
- Fredric N. EshelmanExecutive Officer, Director
- Sigurd C. KirkDirector
- Michael W. RogersDirector
- Peter T.C. HoDirector
- Robert B. GellerExecutive Officer
- Gail McIntyreExecutive Officer, Director
- Leonard Scott DoveExecutive Officer
- Eric ZhangDirector
- Amato GiacciaDirector
- John A. HohneckerDirector
- Offering amount
- $41.6M
- Amount sold
- $41.6M
- Sales commissions
- $1.1M
- Placement agents
- MTS Securities, LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.